These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8946047)

  • 1. ARCON.
    Rojas A
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():34-5. PubMed ID: 8946047
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential for improving radiotherapy outcome by improving the oxygen supply to solid tumours.
    Denekamp J; Waites A
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():22-3. PubMed ID: 8946041
    [No Abstract]   [Full Text] [Related]  

  • 3. ARCON.
    Hoskin PJ; Saunders MI
    Clin Oncol (R Coll Radiol); 1994; 6(5):281-2. PubMed ID: 7826918
    [No Abstract]   [Full Text] [Related]  

  • 4. Mild temperature hyperthermia combined with carbogen breathing increases tumor partial pressure of oxygen (pO2) and radiosensitivity.
    Griffin RJ; Okajima K; Barrios B; Song CW
    Cancer Res; 1996 Dec; 56(24):5590-3. PubMed ID: 8971160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is hyperbaric oxygen more effective than carbogen/nicotinamide in tumor radiation response?
    Hartmann KA; Van der Kleij AJ; Schneider CJ; Sminia P
    Radiat Res; 1997 Nov; 148(5):523-5. PubMed ID: 9355875
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.
    Hoogsteen IJ; Pop LA; Marres HA; Merkx MA; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):83-9. PubMed ID: 16213107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbogen and nicotinamide: expectations too high?
    Brown JM
    Radiother Oncol; 1992 Jun; 24(2):75-6. PubMed ID: 1386679
    [No Abstract]   [Full Text] [Related]  

  • 8. Early skin response to fractionated doses of pions for determining therapeutic gain factors.
    Ohizumi Y; Lam GK; Pickles T; Chaplin DJ
    Tokai J Exp Clin Med; 1996 Jun; 21(2):69-75. PubMed ID: 9239808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy.
    Rojas A; Joiner MC; Denekamp J
    Radiother Oncol; 1992 Jun; 24(2):123-4. PubMed ID: 1386678
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbogen and nicotinamide: expectations too high? (response to J. Martin Brown).
    Horsman MR
    Radiother Oncol; 1992 Jun; 24(2):121-2. PubMed ID: 1386677
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma.
    Hoskin PJ; Rojas AM; Bentzen SM; Saunders MI
    J Clin Oncol; 2010 Nov; 28(33):4912-8. PubMed ID: 20956620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study.
    Hoskin P; Rojas A; Saunders M
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1425-31. PubMed ID: 19036531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
    Miralbell R; Mornex F; Greiner R; Bolla M; Storme G; Hulshof M; Bernier J; Denekamp J; Rojas AM; Pierart M; van Glabbeke M; Mirimanoff RO
    J Clin Oncol; 1999 Oct; 17(10):3143-9. PubMed ID: 10506611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARCON: a novel biology-based approach in radiotherapy.
    Kaanders JH; Bussink J; van der Kogel AJ
    Lancet Oncol; 2002 Dec; 3(12):728-37. PubMed ID: 12473514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.
    Horsman MR; Siemann DW; Nordsmark M; Khalil AA; Overgaard J; Chaplin DJ
    Adv Exp Med Biol; 1994; 361():635-42. PubMed ID: 7597993
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A; Menke D; Dorie MJ; Brown JM
    Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
    Horsman MR; Nordsmark M; Khalil AA; Hill SA; Chaplin DJ; Siemann DW; Overgaard J
    Acta Oncol; 1994; 33(4):371-6. PubMed ID: 8018368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of carboxyhaemoglobin levels in the venous blood of cigarette smokers following the administration of carbogen.
    Macdonald G; Kondor N; Yousefi V; Green A; Wong F; Aquino-Parsons C
    Radiother Oncol; 2004 Dec; 73(3):367-71. PubMed ID: 15588884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comments on hyperbaric oxygen and carbogen/nicotinamide with fractionated radiation.
    Brown JM; Wouters BG
    Radiat Res; 1997 Nov; 148(5):526-7. PubMed ID: 9355876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.